These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1871197)

  • 1. Behavioral tolerance to flurazepam.
    Lau CE; Dolan S; Tang M; Falk JL
    Pharmacol Biochem Behav; 1991 Apr; 38(4):823-7. PubMed ID: 1871197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nature of functional tolerance produced by chronic flurazepam treatment in the cat.
    Rosenberg HC; Chiu TH
    Eur J Pharmacol; 1982 Jul; 81(3):357-65. PubMed ID: 7117380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance during chronic benzodiazepine treatment associated with decreased receptor binding.
    Rosenberg HC; Chiu TH
    Eur J Pharmacol; 1981 Apr; 70(4):453-60. PubMed ID: 7238571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential tolerance to the antipentylenetetrazol activity of benzodiazepines in flurazepam-treated rats.
    Rosenberg HC; Tietz EI; Chiu TH
    Pharmacol Biochem Behav; 1991 Jul; 39(3):711-6. PubMed ID: 1686104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid down-regulation of [3H]zolpidem binding to rat brain benzodiazepine receptors during flurazepam treatment.
    Wu Y; Rosenberg HC; Chiu TH
    Eur J Pharmacol; 1995 May; 278(2):125-32. PubMed ID: 7671997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral tolerance and cross-tolerance to dl-cathinone and d-amphetamine in rats.
    Foltin RW; Schuster CR
    J Pharmacol Exp Ther; 1982 Jul; 222(1):126-31. PubMed ID: 7086694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of in vivo interactions in mice between flurazepam and two neuroactive steroids.
    Deutsch SI; Rosse RB; Steinberg K; Morn C; Koetzner L; Riggs R; Mastropaolo J
    Pharmacol Biochem Behav; 1996 Nov; 55(3):323-6. PubMed ID: 8951972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerance to the disruptive effects of arecoline on schedule-controlled behavior.
    Meltzer LT; Rosecrans JA
    Psychopharmacology (Berl); 1982; 77(1):85-93. PubMed ID: 6812123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral measurement of benzodiazepine tolerance and GABAergic subsensitivity in the substantia nigra pars reticulata.
    Tietz EI; Rosenberg HC
    Brain Res; 1988 Jan; 438(1-2):41-51. PubMed ID: 2830945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of flurazepam on sleep in the laboratory.
    Johns MW; Masterton JP
    Pharmacology; 1974; 11(6):358-64. PubMed ID: 4369953
    [No Abstract]   [Full Text] [Related]  

  • 11. Benzodiazepine--specific and nonspecific tolerance following chronic flurazepam treatment.
    Rosenberg HC; Smith S; Chiu TH
    Life Sci; 1983 Jan; 32(3):279-85. PubMed ID: 6296589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual effects of flurazepam and brotizolam on psychomotor performance.
    Krueger H; Müller-Limmroth W
    Br J Clin Pharmacol; 1983; 16 Suppl 2(Suppl 2):347S-351S. PubMed ID: 6661380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic flurazepam treatment on firing rate of rat substantia nigra pars reticulata neurons.
    Tyma JL; Rosenberg HC; Tietz EI; Chiu TH
    Brain Res; 1988 Jun; 453(1-2):344-8. PubMed ID: 3401772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of interleukin-1 receptor signaling in the behavioral effects of ethanol and benzodiazepines.
    Blednov YA; Benavidez JM; Black M; Mayfield J; Harris RA
    Neuropharmacology; 2015 Aug; 95():309-20. PubMed ID: 25839897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of benzodiazepine anticonvulsant cross-tolerance according to time following flurazepam or diazepam treatment.
    Rosenberg HC
    Pharmacol Biochem Behav; 1995; 51(2-3):363-8. PubMed ID: 7667354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bedtime flurazepam and the human circadian rhythm of spontaneous motility.
    Crowley TJ; Hydinger-Macdonald M
    Psychopharmacology (Berl); 1979 Apr; 62(2):157-61. PubMed ID: 37542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonist-induced reversal of functional and structural measures of hippocampal benzodiazepine tolerance.
    Tietz EI; Zeng XJ; Chen S; Lilly SM; Rosenberg HC; Kometiani P
    J Pharmacol Exp Ther; 1999 Dec; 291(3):932-42. PubMed ID: 10565808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of flurazepam and zopiclone on the performance of chronic insomniac patients: a study of ethanol-drug interaction.
    Mamelak M; Buck L; Csima A; Price V; Smiley A
    Sleep; 1987; 10 Suppl 1():79-87. PubMed ID: 3438646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambulatory motor activity monitoring to study the timecourse of hypnotic action.
    Borbély AA
    Br J Clin Pharmacol; 1984; 18 Suppl 1(Suppl 1):83S-86S. PubMed ID: 6151851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Learned taste aversions induced by hypnotic drugs.
    Vogel JR; Nathan BA
    Pharmacol Biochem Behav; 1975; 3(2):189-94. PubMed ID: 1144479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.